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PRESS STATEMENT BY THE MINISTER FOR HEALTH. PR D.N. EVERINGHAM 
ADVERTISING RESTRICTIONS ON PAIN-KILLING PREPARATIONS 
The Minister for Health, Dr D.N. Everingham, said today 
that Federal and State health authorities could be in a position 
soon to introduce new restrictions on the advertising of non-
prescription minor analgesics (headache and pain relieving preparations). 
Dr Everingham said that the incidence of analgesic 
nephropathy, a kidney disease associated with the abuse of certain 
pain-killing preparations, had now reached serious proportions in 
Australia. 
He said the disease was more common in Australia than 
elsewhere in the world and he believed the time had come for 
national initiative in the matter. 
Dr Everingham said the legislative authority concerning 
the protection of the public against the indiscriminate advertising 
and sale of analgesics rested with the States primarily, although 
the Federal Government had power under the Broadcasting and Television 
Act to approve all radio and television advertising of the products. 
He said that the Federal Government was ready to 
introduce new restrictions on analgesic advertising on radio 
and television, and would do so as soon as agreement had been 
reached with the States on other forms of advertising. 
By August the States would be in a position to study 
new proposa-s dravn up by the National Therapeutic Goods Committee 
for the advertising of all therapeutic goods, including analgesics. 
(The National Therapeutic Goods Committee consists of 
senior officers from the Federal and State Health Departments). 
The proposals of the Committee would be presented to the 
next annual conference of Federal and State Health Ministers. 
Dr Everingham said it was within the powers of the 
Federal Government to implement the new radio and television advertising 
restrictions immediately, but it would be more appropriate that such 
restrictions cover all media, in all states. 
He said that the kind of restrictions being proposed by 
the National Therapeutic Goods Committee would disallow the advertising 
of analgesics unless the advertisement gave full, balanced information 
on such things as precautions, harmful side effects, contra-indications Dunstan Collection, Special Collections, Flinders University Library.
(medical conditions and particular groups of people for which the use 
of the preparation could be harmful), the quantity of active 
constituents in the product, the proper dose and the effectiveness 
and limitations of the product. 
Dr Everingham said the proposals would aim at preventing 
the presentation of a preparation used as a headache or pain reliever 
as being a necessary requirement in daily life. They would preclude 
the radio and television advertising of the products in a dramatised 
form or with accompanying visual or aural matter other than that 
necessary to convey the above information and the name and 
pharmaceutical form of the product. 
He said such restrictions would add further to those which 
already existed which prevented claims being made that analgesic 
comsumption is safe, that it will relax, relieve tension, sedate or 
stimulate, or that any one preparation has qualities which make it 
superior to another. 
In addition to the proposed advertising restrictions, 
the National Health and Medical Research Council has already made 
a recommendation that proprietary preparations containing aspirin, 
phenacetin and paracetamol should be labelled with a warning of the 
danger of taking large amounts over a long period. 
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